RecruitingNot ApplicableNCT05483283
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
Sponsor
University of Illinois at Chicago
Enrollment
600 participants
Start Date
Jan 18, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The investigator and study staff will identify, recruit and randomize Latina participants with elevated genetic and Social Determinants of Heath (SDH) risks. Within 1 week of enrollment, all Latina Aim 1 participants in both study arms will engage in three 30-minute, individual, phone-based sessions with the study team across 3 consecutive weeks
Eligibility
Sex: FEMALEMin Age: 30 Years
Inclusion Criteria19
- Aim 1
- female biological sex
- identification as Latina
- one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer)
- one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges)
- + years old, based on American Cancer Society (ACS) screening guidelines for high risk populations
- No receipt of cancer genetic counseling AND no receipt of genetic testing
- Aim 2
- female biological sex
- referral from Latina Aim 1 participants
- eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual
- screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older)
- self-report not attending Session #3 (as this will not be recorded by the staff)
- Aim 3
- participant from Aim 1 or
- participant from Aim 2
- Aim 3
- Not a participant from Aim 1 or
- Not a participant from Aim 2
Interventions
OTHEREmpowerment and Navigation
Empowerment and Navigation
OTHERSOC
SOC
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05483283
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location